Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Cash Flows From Operating Activities | |||||
| Other Working Capital | -634,000 | -5,157 | -212,000 | -483,000 | -43,000 |
| Other Operating Activity | 2,164,000 | 1,742,996 | 99,000 | 1,518,000 | 1,739,000 |
| Operating Cash Flow | $1,530,000 | $1,737,839 | $-113,000 | $1,035,000 | $1,696,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -689,000 | -535,472 | -351,000 | -240,000 | -245,000 |
| Net Acquisitions | -233,000 | -245,965 | 6,000 | -34,000 | 6,000 |
| Purchase Of Investment | -141,000 | -34,926 | -22,000 | -6,000 | -7,000 |
| Sale Of Investment | 14,000 | 10,156 | 6,000 | 11,000 | 5,000 |
| Other Investing Activity | 93,000 | 166,696 | -166,000 | 86,000 | 70,000 |
| Investing Cash Flow | $-956,000 | $-639,511 | $-527,000 | $-183,000 | $-171,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 440,000 | N/A | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | 43,000 | -584,000 | -333,000 |
| Common Stock Issued | 255,000 | 86,025 | 54,000 | 145,000 | 182,000 |
| Common Stock Repurchased | -575,000 | -533,482 | -309,000 | -305,000 | -200,000 |
| Dividend Paid | -671,000 | -618,966 | -619,000 | -791,000 | -568,000 |
| Other Financing Activity | -103,000 | -231,285 | -75,000 | -53,000 | -80,000 |
| Financing Cash Flow | $-654,000 | $-1,297,708 | $-906,000 | $-1,588,000 | $-999,000 |
| Exchange Rate Effect | 9,000 | -241,674 | 112,000 | N/A | N/A |
| Beginning Cash Position | -2,450,000 | -2,118,000 | -655,000 | -372,000 | -1,237,000 |
| End Cash Position | -3,001,000 | 1,761,425 | -2,118,000 | -655,000 | -372,000 |
| Net Cash Flow | $-80,000 | $-199,381 | $-1,546,000 | $-736,000 | $526,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,530,000 | 1,737,839 | -113,000 | 1,035,000 | 1,696,000 |
| Capital Expenditure | -708,000 | -538,417 | -442,000 | -342,000 | -267,000 |
| Free Cash Flow | 822,000 | 1,199,422 | -555,000 | 693,000 | 1,429,000 |